Aminoglycoside-induced suppression of CYP2C19*3 premature stop codon.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 21934639)

Published in Pharmacogenet Genomics on November 01, 2011

Authors

Mateus Fuchshuber-Moraes1, Renato Sampaio Carvalho, Christian Rimmbach, Dieter Rosskopf, Marcelo Alex Carvalho, Guilherme Suarez-Kurtz

Author Affiliations

1: Instituto Nacional de Câncer, Divisão de Farmacologia, Instituto Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Articles by these authors

SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet (2008) 4.67

Cohort profile: the study of health in Pomerania. Int J Epidemiol (2010) 4.38

Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups. PLoS Genet (2010) 3.21

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups. Blood (2010) 2.93

A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet (2007) 2.75

The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS One (2011) 2.72

Comment on "A common genetic variant is associated with adult and childhood obesity". Science (2007) 1.93

Cluster headache: clinical presentation, lifestyle features, and medical treatment. Headache (2006) 1.86

A genome-wide association study identifies three loci associated with mean platelet volume. Am J Hum Genet (2008) 1.81

Associations between the oxytocin receptor gene (OXTR) and affect, loneliness and intelligence in normal subjects. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.77

Inverse association between serum free thyroxine levels and hepatic steatosis: results from the Study of Health in Pomerania. Thyroid (2012) 1.62

Race and ancestry in biomedical research: exploring the challenges. Genome Med (2009) 1.55

CYP2C9 genotypes and the pharmacokinetics of tenoxicam in Brazilians. Clin Pharmacol Ther (2004) 1.51

Ether à go-go potassium channel expression in soft tissue sarcoma patients. Mol Cancer (2006) 1.42

Serotonin transporter gene (SLC6A4) promoter polymorphisms and the susceptibility to posttraumatic stress disorder in the general population. Am J Psychiatry (2009) 1.36

Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and society. OMICS (2009) 1.35

Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes (2009) 1.28

Meta-analysis of the INSIG2 association with obesity including 74,345 individuals: does heterogeneity of estimates relate to study design? PLoS Genet (2009) 1.18

Direct stimulation of receptor-controlled phospholipase D1 by phospho-cofilin. EMBO J (2007) 1.14

Cyclic AMP-dependent and Epac-mediated activation of R-Ras by G protein-coupled receptors leads to phospholipase D stimulation. J Biol Chem (2006) 1.12

Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation (2006) 1.09

The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men. Br J Clin Pharmacol (2010) 1.04

Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. J Clin Endocrinol Metab (2009) 1.04

Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men. Int J Androl (2009) 1.04

Survey of Neonates in Pomerania (SNiP): a population-based birth study--objectives, design and population coverage. Paediatr Perinat Epidemiol (2010) 1.00

Distribution of ABCB1 polymorphisms among Brazilians: impact of population admixture. Pharmacogenomics (2008) 0.98

Worldwide allele frequency distribution of four polymorphisms associated with warfarin dose requirements. J Hum Genet (2010) 0.98

ABCB1 polymorphisms and the concentrations of lopinavir and ritonavir in blood, semen and saliva of HIV-infected men under antiretroviral therapy. Pharmacogenomics (2009) 0.98

Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.97

Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians. Basic Clin Pharmacol Toxicol (2011) 0.95

Expression analysis and potential functional role of the CXCR4 chemokine receptor in bladder cancer. Eur Urol (2005) 0.93

Genetic epistasis between the brain-derived neurotrophic factor Val66Met polymorphism and the 5-HTT promoter polymorphism moderates the susceptibility to depressive disorders after childhood abuse. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.93

Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer. Br J Clin Pharmacol (2014) 0.92

Development of a rapid and specific assay for detection of busulfan in human plasma by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom (2005) 0.91

Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1. Pharmacogenet Genomics (2008) 0.91

A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library. Proc Natl Acad Sci U S A (2009) 0.91

Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients. Pharmacogenomics (2011) 0.90

Combined CYP2C9, VKORC1 and CYP4F2 frequencies among Amerindians, Mozambicans and Brazilians. Pharmacogenomics (2011) 0.90

Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin. Drug Metab Dispos (2009) 0.89

Influence of DRD2 and ANKK1 genotypes on apomorphine-induced growth hormone (GH) response in alcohol-dependent patients. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.89

Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme. BMC Cancer (2013) 0.89

Rap2B-dependent stimulation of phospholipase C-epsilon by epidermal growth factor receptor mediated by c-Src phosphorylation of RasGRP3. Mol Cell Biol (2004) 0.89

Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil. Drug Metab Dispos (2010) 0.88

Associations between the oxytocin receptor gene (OXTR) and "mind-reading" in humans--an exploratory study. Nord J Psychiatry (2012) 0.87

Relative contribution of VKORC1, CYP2C9, and INR response to warfarin stable dose. Blood (2009) 0.86

Selective, direct activation of high-conductance, calcium-activated potassium channels causes smooth muscle relaxation. Mol Pharmacol (2012) 0.86

A rapid and sensitive method for simultaneous determination of lamivudine and zidovudine in human serum by on-line solid-phase extraction coupled to liquid chromatography/tandem mass spectrometry detection. Rapid Commun Mass Spectrom (2004) 0.86

Pharmacogenomics and the genetic diversity of the Brazilian population. Cad Saude Publica (2009) 0.85

Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men. J Androl (2008) 0.85

Study of membrane potential in T lymphocytes subpopulations using flow cytometry. BMC Immunol (2008) 0.85

Predictors of acute treatment response among patients with cluster headache. Headache (2007) 0.85

Distribution of the GNB3 825C>T polymorphism among Brazilians: impact of population structure. Eur J Clin Pharmacol (2007) 0.84

Selection of a common multipotent cardiovascular stem cell using the 3.4-kb MesP1 promoter fragment. Basic Res Cardiol (2012) 0.84

Inhibition of glycogen synthase kinase 3beta prevents peroxide-induced collapse of mitochondrial membrane potential in rat ventricular myocytes. Clin Exp Pharmacol Physiol (2010) 0.84

Disposition and sterol-lowering effect of ezetimibe are influenced by single-dose coadministration of rifampin, an inhibitor of multidrug transport proteins. Clin Pharmacol Ther (2006) 0.83

Role of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with delta-storage pool deficiencies. Am J Pathol (2010) 0.83

Determination of lopinavir and ritonavir in blood plasma, seminal plasma, saliva and plasma ultra-filtrate by liquid chromatography/tandem mass spectrometry detection. Rapid Commun Mass Spectrom (2008) 0.82

Moderation of adult depression by the serotonin transporter promoter variant (5-HTTLPR), childhood abuse and adult traumatic events in a general population sample. Am J Med Genet B Neuropsychiatr Genet (2012) 0.82

Comment on "Genetically determined differences in learning from errors". Science (2008) 0.82

Thiopurine methyltransferase phenotypes and genotypes in Brazilians. Pharmacogenetics (2003) 0.81

Alcohol consumption is associated with an interaction between DRD2 exon 8 A/A genotype and self-directedness in males. Neuropsychobiology (2007) 0.81

Potassium channels in T lymphocytes: therapeutic targets for autoimmune disorders? BioDrugs (2004) 0.81

Enhanced stem cell migration mediated by VCAM-1/VLA-4 interaction improves cardiac function in virus-induced dilated cardiomyopathy. Basic Res Cardiol (2013) 0.81

Concentration of the macrolide antibiotic tulathromycin in broncho-alveolar cells is influenced by comedication of rifampicin in foals. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.81

Malaria downmodulates mRNA expression and catalytic activities of CYP1A2, 2E1 and 3A11 in mouse liver. Eur J Pharmacol (2009) 0.80

Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer. World J Urol (2005) 0.80

VKORC1 polymorphisms in Amerindian populations of Brazil. Pharmacogenomics (2008) 0.80

Inhibition of the myotoxic activities of three African Bitis venoms (B. rhinoceros, B. arietans and B. nasicornis) by a polyvalent antivenom. Toxicon (2009) 0.79

Gastric inhibitory polypeptide receptor: association analyses for obesity of several polymorphisms in large study groups. BMC Med Genet (2009) 0.79

Association between migraine and the G1246A polymorphism in the hypocretin receptor 2 gene. Headache (2007) 0.79

Effects of NS1608, a BK(Ca) channel agonist, on the contractility of guinea-pig urinary bladder in vitro. Br J Pharmacol (2005) 0.78

Investigation of the Lith6 candidate genes APOBEC1 and PPARG in human gallstone disease. Liver Int (2007) 0.78

Shaker-type Kv1 channel blockers increase the peristaltic activity of guinea-pig ileum by stimulating acetylcholine and tachykinins release by the enteric nervous system. Br J Pharmacol (2003) 0.78

Influence of CYP2C9 genotypes on the pharmacokinetics and pharmacodynamics of piroxicam. Clin Pharmacol Ther (2005) 0.78

Exploring warfarin pharmacogenomics with the extreme-discordant-phenotype methodology: impact of FVII polymorphisms on stable anticoagulation with warfarin. Eur J Clin Pharmacol (2009) 0.78

Association of the UGT1A1-53(TA)n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancer. Pharmacogenet Genomics (2011) 0.77

Linkage disequilibrium between the CYP2C19*17 and CYP2C8*2 alleles in populations of African descent. Eur J Clin Pharmacol (2010) 0.77

MTHFR 677C>T polymorphism and cluster headache. Headache (2010) 0.77

Increased numbers of bone marrow-derived cells in parathyroid adenoma. Eur J Clin Invest (2014) 0.77

Impact of CYP2C9*3/*3 genotype on the pharmacokinetics and pharmacodynamics of piroxicam. Clin Pharmacol Ther (2006) 0.77

Limited penetration of lopinavir and ritonavir in the genital tract of men infected with HIV-1 in Brazil. Ther Drug Monit (2006) 0.77

Stroma-mediated granulocyte-macrophage colony-stimulating factor (GM-CSF) control of myelopoiesis: spatial organisation of intercellular interactions. Cell Tissue Res (2003) 0.77

Detection of CYP2C9*5 in a white Brazilian subject. Clin Pharmacol Ther (2005) 0.76

Function-impairing polymorphisms of the hepatic uptake transporter SLCO1B1 modify the therapeutic efficacy of statins in a population-based cohort. Pharmacogenet Genomics (2015) 0.76

Accuracy of NAT2 SNP genotyping panels to infer acetylator phenotypes in African, Asian, Amerindian and admixed populations. Pharmacogenomics (2012) 0.76

Metabolic activation and analgesic effect of flupirtine in healthy subjects, influence of the polymorphic NAT2, UGT1A1 and GSTP1. Br J Clin Pharmacol (2015) 0.75

Influence of the CYP2C9*3 allele on the pharmacological interaction between warfarin and simvastatin. Pharmacogenomics (2012) 0.75

Bi-allelic and tri-allelic 5-HTTLPR polymorphisms and triptan non-response in cluster headache. J Headache Pain (2014) 0.75

β-blocker therapy and heart rate control during exercise testing in the general population: role of a common G-protein β-3 subunit variant. Pharmacogenomics (2010) 0.75

Determination of stavudine in human serum by on-line solid-phase extraction coupled to high-performance liquid chromatography with electrospray ionization tandem mass spectrometry: application to a bioequivalence study. Rapid Commun Mass Spectrom (2003) 0.75

Demographic history and human genetic diversity: pharmacogenomic implications. Pharmacogenomics (2014) 0.75

Determination of didanosine in human serum by on-line solid-phase extraction coupled to high-performance liquid chromatography with electrospray ionization tandem mass spectrometric detection: application to a bioequivalence study. J Mass Spectrom (2003) 0.75